Vitrolife AB (publ) (OTCMKTS:VTRLY) Stock Price Up 1,087.4% – Time to Buy?

Vitrolife AB (publ) (OTCMKTS:VTRLY)’s stock price rose 1,087.4% on Tuesday . The company traded as high as $178.8848 and last traded at $178.8848. Approximately 224,328 shares changed hands during trading, an increase of 55,982% from the average daily volume of 400 shares. The stock had previously closed at $15.0650.

Vitrolife AB (publ) Price Performance

The business has a fifty day moving average of $18.73 and a 200-day moving average of $16.86.

Vitrolife AB (publ) Company Profile

Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.

The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.